Compare LGL & BEAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LGL | BEAT |
|---|---|---|
| Founded | 1917 | 2015 |
| Country | United States | United States |
| Employees | 7 | 16 |
| Industry | Industrial Machinery/Components | Retail: Computer Software & Peripheral Equipment |
| Sector | Technology | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 40.9M | 44.8M |
| IPO Year | N/A | N/A |
| Metric | LGL | BEAT |
|---|---|---|
| Price | $7.13 | $1.18 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $5.63 |
| AVG Volume (30 Days) | 4.4K | ★ 737.3K |
| Earning Date | 05-14-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $260.78 |
| P/E Ratio | $42.61 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $5.45 | $0.54 |
| 52 Week High | $9.55 | $4.00 |
| Indicator | LGL | BEAT |
|---|---|---|
| Relative Strength Index (RSI) | 50.39 | 41.94 |
| Support Level | $6.90 | $1.17 |
| Resistance Level | $7.36 | $1.35 |
| Average True Range (ATR) | 0.20 | 0.08 |
| MACD | -0.02 | 0.01 |
| Stochastic Oscillator | 49.30 | 36.00 |
LGL Group Inc is a holding company engaged in services, merchant investment and manufacturing business activities. The company has two reportable segments; Electronic Instruments and Merchant Investment. The Electronic Instruments segment, which generates key revenue, is focused on designing and manufacturing high-performance Frequency and Time reference standards that form the basis for timing and synchronization in various applications including satellite communication, time transfer systems, network synchronization, electricity distribution, and metrology. The Merchant Investment segment comprises various investment vehicles in which the company invests its capital.
HeartBeam Inc is a medical technology company focused on developing higher resolution ambulatory electrocardiogram (ECG) solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility setting. The company's proprietary and patented technology platform captures the heart's electrical activity from three dimensions and synthesizes a 12-lead ECG from these signals. The company has received U.S. Food and Drug Administration (FDA) clearance for its ECG solutions.